Annual Drug Patent Expirations for AUGTYRO
Augtyro is a drug marketed by Bristol and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
This drug has ninety patent family members in thirty-two countries.
The generic ingredient in AUGTYRO is repotrectinib. One supplier is listed for this compound. Additional details are available on the repotrectinib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com